Entresto

Boehringer, Lilly hail Jardiance data in hard-to-treat heart failure

https://pharmaphorum.com/news/boehringer-lilly-hail-jardiance-data-in-hard-to-treat-heart-failure/

Entresto set for big sales hike after FDA panel endorsement

https://pharmaphorum.com/news/entresto-set-for-big-sales-hike-after-fda-panel-endorsement/

Novartis CEO thinks 2nd health lockdown unlikely, as Q3 sales stabilise

https://pharmaphorum.com/news/novartis-ceo-thinks-2nd-health-lockdown-unlikely-as-q3-sales-stabilise/

Despite trial miss, Novartis still believes in Entresto for HFpEF

https://pharmaphorum.com/news/despite-trial-miss-novartis-still-believes-in-entresto-for-hfpef/

Entresto tops mainstay ACE inhibitor in heart failure trial

https://pharmaphorum.com/news/entresto-tops-mainstay-ace-inhibitor-in-heart-failure-trial/

The biggest pharma stories of 2016 so far

https://pharmaphorum.com/views-and-analysis/biggest-pharma-stories-2016-far/

Novartis ramping up investment in new drugs

https://pharmaphorum.com/news/novartis-ramping-investment-new-drugs/

10 drugs – and their prices – which changed pharma in 2015

https://pharmaphorum.com/views-and-analysis/10-drugs-and-their-prices-which-changed-pharma-in-2015/

Close in 10 seconds

Pharmaphorum.com

Search